Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-08-12 Sale |
2024-08-14 4:24 pm |
Aldeyra Therapeutics Inc. | ALDX | Machatha Stephen Chief Development Officer |
16,041 | $4.7363 | $75,975 | 236,771 (Direct) |
View |
| 2024-03-12 Sale(A) |
2024-04-17 4:12 pm |
Aldeyra Therapeutics Inc. | ALDX | Machatha Stephen Chief Development Officer |
11,537 | $3.164 | $36,503 | 252,812 (Direct) |
View |
| 2024-03-11 Sale |
2024-03-12 8:04 pm |
Aldeyra Therapeutics Inc. | ALDX | Machatha Stephen Chief Development Officer |
29,768 | $3.3125 | $98,605 | 649,156 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-04 Option Award |
2025-03-06 4:13 pm |
N/A 2035-03-03 |
Aldeyra Therapeutics Inc. | ALDX | Machatha Stephen Chief Development Officer |
202,427 | $0 | 202,427 (Direct) |
View |
| 2024-03-09 Option Award |
2024-03-12 8:04 pm |
N/A 2034-03-08 |
Aldeyra Therapeutics Inc. | ALDX | Machatha Stephen Chief Development Officer |
405,450 | $0 | 649,156 (Direct) |
View |
| 2023-02-28 Option Award |
2023-03-02 4:27 pm |
N/A 2033-02-27 |
Aldeyra Therapeutics Inc. | ALDX | Machatha Stephen Chief Development Officer |
220,258 | $0 | 220,258 (Direct) |
View |
| 2022-07-15 Option Award |
2022-07-19 4:34 pm |
N/A N/A |
Aldeyra Therapeutics Inc. | ALDX | Machatha Stephen Chief Development Officer |
255,078 | $0 | 342,947 (Direct) |
View |
| 2022-03-30 Option Award |
2022-04-01 7:37 pm |
N/A 2032-03-29 |
Aldeyra Therapeutics Inc. | ALDX | Machatha Stephen Chief Development Officer |
314,395 | $0 | 337,869 (Direct) |
View |
| 2021-04-12 Option Award |
2021-04-14 7:24 pm |
N/A 2031-04-11 |
Aldeyra Therapeutics Inc. | ALDX | Machatha Stephen Chief Development Officer |
116,201 | $0 | 116,201 (Direct) |
View |
Ownership |
2020-12-18 6:06 pm |
N/A N/A |
Aldeyra Therapeutics Inc. | ALDX | Machatha Stephen Chief Development Officer |
0 | $0 | 325,635 (Direct) |
View |